Pancreatic Cancer | Topics

Maintenance Olaparib May Be Cost-Effective for BRCA-Mutated Metastatic Pancreatic Cancer
November 19, 2020

Study results suggested that maintenance olaparib (Lynparza) is potentially cost-effective compared with placebo for patients with metastatic pancreatic cancer and a germline BRCA mutation.

Oncology Peer Review On-The-Go: Barriers to Pancreatic Cancer Clinical Trial Enrollment
November 11, 2020

The latest installment of “Oncology Peer Review On-The-Go” dissects original research published in the journal ONCOLOGY regarding potential barriers to clinical trial enrollment for patients with pancreatic cancer.

Weight Loss Surgery May Decrease Risk of Developing Pancreatic Cancer in Obese, Diabetic Patients
November 01, 2020

This 20-year analysis suggested that weight loss surgery significantly decreases the risk of developing pancreatic cancer in individuals who are obese with diabetes.